Clinical Trial

Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists

Study acronym: TRICHECO
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134a in Chinese patients with asthma uncontrolled on medium doses of ICS+LABA.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-09
Trial Details
NCT Number NCT07546981
Lead Sponsor Chiesi Farmaceutici S.p.A.
Conditions Asthma
Enrollment 554 participants
Start Date 2026-06-26
Primary Completion 2028-10-17 (estimated)
Study Completion 2028-10-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-08